Comparison of the effects of doxycycline and povidone iodine in treatment of pleural effusion; an open label randomized clinical trial

被引:1
|
作者
Hemmati, Hamid Reza [1 ]
Hadjizadeh, Armin [1 ]
Malek, Farhad [2 ]
Ghorbani, Raheb [3 ]
Zahmatkesh, Mehrdad [4 ]
Soltani, Setareh [1 ]
机构
[1] Semnan Univ Med Sci, Dept Surg, Semnan, Iran
[2] Semnan Univ Med Sci, Dept Internal Med, Semnan, Iran
[3] Semnan Univ Med Sci, Social Determinants Hlth Res Ctr, Semnan, Iran
[4] Semnan Univ Med Sci, Nursing Care Res Ctr, Semnan, Iran
来源
IMMUNOPATHOLOGIA PERSA | 2024年 / 10卷 / 02期
关键词
Pleurodesis; Povidone iodine; Doxycycline; Malignant pleural effusion; IODOPOVIDONE PLEURODESIS; EFFICACY; SAFETY; BLEOMYCIN;
D O I
10.34172/ipp.2022.13186
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Introduction: Doxycycline is commonly used in treating pleural effusion. Povidone-iodine is another agent that has been used for treating pleural effusion. Objectives: We aimed to compare the effects of doxycycline and povidone iodine in treating pleural effusion. Patients and Methods: Forty-one patients with pleural effusion were enrolled and randomly divided into two groups. After insertion of the chest tube, pleurodesis was performed in the first group with povidone iodine and doxycycline in the second group. The chest tube clamped and opened one hour later. Then, connected to the suction through a double chest bottle. By decreasing of drainage to less than 50 cc per day, the chest tube was removed and the patients were evaluated three days later for pain, fever, empyema, recurrent effusion and long-term side effects at 7(th), 30(th), 60(th) and 90(th) day. Results: The pain intensity was not different between two groups (P > 0.05). None of the patients had empyema and other side effects including hemothorax or pneumothorax were not seen too. In a 90-day follow-up, 47.6% of doxycycline recipients and 25% of povidone iodine recipients experienced the recurrent effusion (P = 0.133). Three patients had fever (one on the first day and two on the second day) in the doxycycline group, while fever was not observed in povidone iodine recipients. The cost of treatment in both groups was almost the same. Conclusion: Side effects of pleurodesis include pain, fever, recurrent effusion, cost in the two groups is almost equal, and both agents can be used as an effective drug for treating pleural effusion.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Virucidal effect of povidone iodine on COVID-19 in the nasopharynx: an open-label randomized clinical trial
    Mostafa Kamal Arefin
    S. K. Nurul Fattah Rumi
    A. K. M. Nasir Uddin
    Sultana Sahana Banu
    Mala Khan
    Ahsanul Kaiser
    Joybaer Anam Chowdhury
    Md. Abdullah Saeed Khan
    Mohammad Jahid Hasan
    Indian Journal of Otolaryngology and Head & Neck Surgery, 2022, 74 : 2963 - 2967
  • [2] Virucidal effect of povidone iodine on COVID-19 in the nasopharynx: an open-label randomized clinical trial
    Arefin, Mostafa Kamal
    Rumi, S. K. Nurul Fattah
    Uddin, A. K. M. Nasir
    Banu, Sultana Sahana
    Khan, Mala
    Kaiser, Ahsanul
    Chowdhury, Joybaer Anam
    Khan, Md Abdullah Saeed
    Hasan, Mohammad Jahid
    INDIAN JOURNAL OF OTOLARYNGOLOGY AND HEAD & NECK SURGERY, 2022, 74 (SUPPL 2) : 2963 - 2967
  • [3] Virucidal Effect of Povidone Iodine on SARS-CoV-2 in Nasopharynx: An Open-label Randomized Clinical Trial
    Arefin, Mostafa Kamal
    Banu, Sultana Sahana
    Uddin, A. K. M. Nasir
    Rumi, S. K. Nurul Fattah
    Khan, Mala
    Kaiser, Ahsanul
    Arafat, Muhammad Shaharior
    Chowdhury, Joybaer Anam
    Khan, Md Abdullah Saeed
    Hasan, Mohammad Jahid
    INDIAN JOURNAL OF OTOLARYNGOLOGY AND HEAD & NECK SURGERY, 2022, 74 (SUPPL 2) : 3283 - 3292
  • [4] Virucidal Effect of Povidone Iodine on SARS-CoV-2 in Nasopharynx: An Open-label Randomized Clinical Trial
    Mostafa Kamal Arefin
    Sultana Sahana Banu
    A. K. M. Nasir Uddin
    S. K. Nurul Fattah Rumi
    Mala Khan
    Ahsanul Kaiser
    Muhammad Shaharior Arafat
    Joybaer Anam Chowdhury
    Md. Abdullah Saeed Khan
    Mohammad Jahid Hasan
    Indian Journal of Otolaryngology and Head & Neck Surgery, 2022, 74 : 3283 - 3292
  • [5] Comparison of Efficacy and Safety of Talc to Povidone-Iodine Pleurodesis in Malignant Pleural Effusion: A Systematic Review and Meta-Analysis
    Balan, Divya
    Baral, Tejaswini
    Manu, Mohan K.
    Mohapatra, Aswini Kumar
    Miraj, Sonal Sekhar
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2025, 46 (01) : 24 - 30
  • [6] Virucidal effect of povidone iodine on COVID-19 in the nasopharynx: A structured summary of a study protocol for an open-label randomized clinical trial
    Mohammad Jahid Hasan
    S. K. Nurul Fattah Rumi
    Sultana Sahana Banu
    A. K. M. Nasir Uddin
    Md Shahnoor Islam
    Mostafa Kamal Arefin
    Trials, 22
  • [7] Virucidal effect of povidone iodine on COVID-19 in the nasopharynx: A structured summary of a study protocol for an open-label randomized clinical trial
    Hasan, Mohammad Jahid
    Rumi, S. K. Nurul Fattah
    Banu, Sultana Sahana
    Uddin, A. K. M. Nasir
    Islam, Md Shahnoor
    Arefin, Mostafa Kamal
    TRIALS, 2021, 22 (01)
  • [8] Role of doxycycline in the treatment of dengue infection: An open-label, randomized, controlled, pilot trial
    Kumar, Banothu Vinod
    Kamboj, Kajal
    Pannu, Ashok Kumar
    Yadav, Ashok Kumar
    Bhatia, Mandip
    Saroch, Atul
    ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE, 2024, 17 (04) : 160 - 165
  • [9] A Prospective, Open-label, Randomized Trial of Doxycycline Versus Azithromycin for the Treatment of Uncomplicated Murine Typhus
    Newton, Paul N.
    Keolouangkhot, Valy
    Lee, Sue J.
    Choumlivong, Khamla
    Sisouphone, Siho
    Choumlivong, Khamloune
    Vongsouvath, Manivanh
    Mayxay, Mayfong
    Chansamouth, Vilada
    Davong, Viengmon
    Phommasone, Koukeo
    Sirisouk, Joy
    Blacksell, Stuart D.
    Nawtaisong, Pruksa
    Moore, Catrin E.
    Castonguay-Vanier, Josee
    Dittrich, Sabine
    Rattanavong, Sayaphet
    Chang, Ko
    Darasavath, Chirapha
    Rattanavong, Oudayvone
    Paris, Daniel H.
    Phetsouvanh, Rattanaphone
    CLINICAL INFECTIOUS DISEASES, 2019, 68 (05) : 738 - 747
  • [10] Comparison of Repeated Doses of Ivermectin Versus Ivermectin Plus Albendazole for the Treatment of Onchocerciasis: A Randomized, Open-label, Clinical Trial
    Debrah, Linda Batsa
    Klarmann-Schulz, Ute
    Osei-Mensah, Jubin
    Dubben, Bettina
    Fischer, Kerstin
    Mubarik, Yusif
    Ayisi-Boateng, Nana Kwame
    Ricchiuto, Arcangelo
    Fimmers, Rolf
    Konadu, Peter
    Nadal, Jennifer
    Gruetzmacher, Barbara
    Weil, Gary
    Kazura, James W.
    King, Christopher L.
    Debrah, Alexander Y.
    Hoerauf, Achim
    CLINICAL INFECTIOUS DISEASES, 2020, 71 (04) : 933 - 943